Bio-Techne (TECH) Misses Q3 EPS by 8c

Bio-Techne (NASDAQ: TECH) reported Q3 EPS of $0.81, $0.08 worse than the analyst estimate of $0.89. Revenue for the quarter came in at $131 million versus the consensus estimate of $122.65 million.

For earnings history and earnings-related data on Bio-Techne (TECH) click here.

You May Also Be Interested In

• Evercore cuts HPE rating amid 'tougher setup'
• Rent the Runway (RENT) Reports Q2 Loss of $0.38/sh
• Oracle (ORCL) Tops Q1 EPS by 19c, Beats on Revenue; Beats on Cloud Revenue, Offers Q3 EPS Guidance